198 related articles for article (PubMed ID: 36417134)
21. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122.
Randall ME; Spirtos NM; Dvoretsky P
J Natl Cancer Inst Monogr; 1995; (19):13-5. PubMed ID: 7577198
[TBL] [Abstract][Full Text] [Related]
22. Personalized therapy in endometrial cancer: challenges and opportunities.
Westin SN; Broaddus RR
Cancer Biol Ther; 2012 Jan; 13(1):1-13. PubMed ID: 22198566
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO).
Morneau M; Foster W; Lalancette M; Van Nguyen-Huynh T; Renaud MC; Samouëlian V; Letarte N; ; ; Almanric K; Boily G; Bouchard P; Boulanger J; Cournoyer G; Couture F; Gervais N; Goulet S; Guay MP; Kavanagh M; Lemieux J; Lespérance B; Letarte N; Morneau M; Ouellet JF; Pineau G; Rajan R; Roy I; Samson B; Sidéris L; Vincent F
Gynecol Oncol; 2013 Oct; 131(1):231-40. PubMed ID: 23872191
[TBL] [Abstract][Full Text] [Related]
24. Updates on adjuvant chemotherapy and radiation therapy for endometrial cancer.
Cowan M; Strauss JB; Barber EL; Matei D
Curr Opin Obstet Gynecol; 2019 Feb; 31(1):31-37. PubMed ID: 30571659
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy of uterine clear cell carcinoma: a review.
Xu Y; Hanna RK; Elshaikh MA
Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy with external beamradiation therapy for high-grade, node-positive endometrial cancer.
Lee LJ; Bu P; Feltmate C; Viswanathan AN
Int J Gynecol Cancer; 2014 Oct; 24(8):1441-8. PubMed ID: 25207463
[TBL] [Abstract][Full Text] [Related]
27. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
[TBL] [Abstract][Full Text] [Related]
28. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
[TBL] [Abstract][Full Text] [Related]
29. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
30. Combined chemotherapy and radiation improves survival for node-positive endometrial cancer.
Lee LJ; Viswanathan AN
Gynecol Oncol; 2012 Oct; 127(1):32-7. PubMed ID: 22735786
[TBL] [Abstract][Full Text] [Related]
31. Cancer of the corpus uteri: 2021 update.
Koskas M; Amant F; Mirza MR; Creutzberg CL
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):45-60. PubMed ID: 34669196
[TBL] [Abstract][Full Text] [Related]
32. A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapy.
Sakai K; Yamagami W; Machida H; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Aoki D; Mikami M
Int J Gynaecol Obstet; 2022 Feb; 156(2):262-269. PubMed ID: 33914336
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and adjuvant chemotherapy in the treatment of endometrial cancer.
Stanojevic Z; Djordjevic B; Todorovska I; Lilic V; Zivadinovic R; Dunjic O
J BUON; 2008; 13(1):23-30. PubMed ID: 18404782
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
35. Treatment modalities in endometrial cancer.
Amant F; Moerman P; Neven P; Timmerman D; Van Limbergen E; Vergote I
Curr Opin Oncol; 2007 Sep; 19(5):479-85. PubMed ID: 17762575
[TBL] [Abstract][Full Text] [Related]
36. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy for endometrial cancer.
Tangjitgamol S; See HT; Kavanagh J
Int J Gynecol Cancer; 2011 Jul; 21(5):885-95. PubMed ID: 21697679
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant treatment of endometrial cancer today.
Aoki Y; Kanao H; Wang X; Yunokawa M; Omatsu K; Fusegi A; Takeshima N
Jpn J Clin Oncol; 2020 Jul; 50(7):753-765. PubMed ID: 32463094
[TBL] [Abstract][Full Text] [Related]
39. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.
Ko EM; Brensinger CM; Cory L; Giuntoli RL; Haggerty AF; Latif NA; Aviles D; Martin L; Morgan MA; Lin LL
Gynecol Oncol; 2020 Nov; 159(2):394-401. PubMed ID: 32800655
[TBL] [Abstract][Full Text] [Related]
40. Carcinoma of the endometrium.
Southcott BM
Drugs; 2001; 61(10):1395-405. PubMed ID: 11558829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
